WWM
OGEN icon

Wolff Wiese Magana’s Oragenics OGEN Stock Holding History

Wolff Wiese Magana’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$25 – 1019
2024
Q4 		$25 Hold
2
– – ﹤0.01% 954
2024
Q3 		$26 Hold
2
– – ﹤0.01% 984
2024
Q2 		$70 Hold
2
– – ﹤0.01% 775
2024
Q1 		$97 Buy
2
+1
+100% +$99 ﹤0.01% 697
2023
Q4 		$96 Hold
1
– – ﹤0.01% 698
2023
Q3 		$51 Hold
1
– – ﹤0.01% 785
2023
Q2 		$57 Hold
1
– – ﹤0.01% 792
2023
Q1 		$56 Hold
1
– – ﹤0.01% 753
2022
Q4 		$105 Hold
1
– – ﹤0.01% 751
2022
Q3 		$0 Hold
1
– – ﹤0.01% 936
2022
Q2 		$0 Hold
1
– – ﹤0.01% 935
2022
Q1 		$0 Hold
1
– – ﹤0.01% 839
2021
Q4 		$0 Hold
1
– – ﹤0.01% 838
2021
Q3 		$1K Hold
1
– – ﹤0.01% 775
2021
Q2 		$1K Hold
1
– – ﹤0.01% 798
2021
Q1 		$1K Buy
+1
New +$1.82K ﹤0.01% 705

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $5.31B AUM 25.12% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wolff Wiese Magana's OGEN Position: Q1 2025 in Review

Wolff Wiese Magana sold out of Oragenics (OGEN) in Q1 2025, closing a stake of 2 shares — an estimated $25 sold.

Wolff Wiese Magana first reported a position in OGEN in Q1 2021 and held it in 16 quarters. The position peaked at $1K in Q3 2021. 17 funds tracked by Wall St. Rank hold OGEN as of Q1 2025.

  • Wolff Wiese Magana reported no remaining Oragenics position as of Q1 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 2 Oragenics shares in Q1 2025, an estimated $25.
  • Wolff Wiese Magana first reported a position in Oragenics in Q1 2021 and held it in 16 quarters.
  • Wolff Wiese Magana's Oragenics position peaked at $1K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q1 2025.

Based on Wolff Wiese Magana's 13F filing for Q1 2025, filed 22 Apr 2025.